Real-time enrollment status for this x-linked myotubular myopathy clinical trial
Current Status
Recruiting
Checked: October 14, 2026 at 3:18 AM UTC
| NCT Number | NCT07052929 |
| Recruiting Status | Recruiting |
| Condition | X-Linked Myotubular Myopathy |
| Phase | PHASE1 |
| Target Enrollment | 9 participants |
| Active Locations | 4 sites in the US |
| Sponsor | Astellas Gene Therapies |
| Last Updated on CT.gov | September 3, 2026 (Sep 3, 2026) |
As of October 14, 2026: Clinical trial NCT07052929 is currently recruiting participants. This phase1 study for x-linked myotubular myopathy is actively seeking new participants at 4 locations across the United States. The study is sponsored by Astellas Gene Therapies. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07052929 is actively recruiting participants as of October 14, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 4 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07052929 was last updated Sep 3, 2026 (September 3, 2026). HelloStudys verifies this status automatically.